Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Immunobiology Research Institute |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002332 |
To evaluate the mechanism whereby thymopentin appears to retard the progressive immune suppression attributable to HIV infection.
Condition | Intervention | Phase |
---|---|---|
HIV Infections |
Drug: Thymopentin |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Double-Blind, Efficacy Study |
Official Title: | Double-Blind Study of the Effect of Timunox (Thymopentin) on Lymphoproliferative Responses and Virus Load in HIV-Infected Subjects Receiving Nucleoside Analog Antiretroviral Therapy |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Patients must have:
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
Concurrent Medication:
Excluded:
Patients with the following prior condition are excluded:
Abnormal chest x-ray consistent with active opportunistic infection within 6 weeks prior to study entry.
Prior Medication:
Excluded:
Required:
Required:
Significant active alcohol or drug abuse sufficient to prevent study compliance.
United States, California | |
Dr Jeffrey Galpin | |
Tarzana, California, United States, 91356 | |
Dr Marcus Conant | |
San Francisco, California, United States, 94115 | |
United States, Pennsylvania | |
Novum Inc | |
Pittsburgh, Pennsylvania, United States, 15206 |
Study ID Numbers: | 015I, 07.32.039-94 |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002332 |
Health Authority: | United States: Food and Drug Administration |
Thymopentin AIDS-Related Complex |
Virus Diseases Sexually Transmitted Diseases, Viral HIV Infections Thymopentin Sexually Transmitted Diseases |
Acquired Immunodeficiency Syndrome AIDS-Related Complex Retroviridae Infections Immunologic Deficiency Syndromes |
RNA Virus Infections Slow Virus Diseases Immunologic Factors Immune System Diseases Physiological Effects of Drugs |
Adjuvants, Immunologic Lentivirus Infections Infection Pharmacologic Actions |